People with a family history of Alzheimer's disease (or memory loss) may have a greater risk for developing the disease. Great Lakes Clinical Trials is conducting a research study of an investigational medication intended to prevent progression to Alzheimer's disease.
This research program is looking for individuals who do not currently have memory loss more than normal aging but are at greater risk for developing it in the future.
Specifically, this includes volunteers between the ages of 65-75 who have had a family history of Alzheimer's disease and carry one or two copies of the Alzheimer's gene (Apoe4). Great Lakes Clinical Trials will provide genetic testing for the Alzheimer's gene. If you do carry one or two copies of the gene, you may be eligible to continue in the program.
The key facts of the program:
• 5 - 8 year clinical trial
• You'll receive an investigational treatment or a placebo
• Regular study site visits (8 in the first year, 4 visits a year thereafter)
• Reasonable travel costs will be reimbursed
• Participation is voluntary, you can leave at any time
If you qualify and enter the program, you'll be joining the fight to prevent Alzheimer's.
For more information or to set up your appointment, call (773) 275-3500 or visit greatlakesclinicaltrials.com/generations